Will the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More
Medicare – General
Medicare Advantage’s growth spurt won’t last forever: McKinsey
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage enrollment has grown rapidly in recent years, now enrolling over half of
Read MoreCMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
(Source – www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered
Read MoreOIG: Medicare overpaid up to $888M for genetic tests
(By Rylee Wilson for Becker’s Hospital Review) Medicare could have overpaid hundreds of millions for genetic testing from 2018 to
Read MoreAn Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read MoreTransforming Medicare Coverage: A New Medicare Coverage Pathway for Emerging Technologies and Revamped Evidence Development Framework
(Source – www.cms.gov) The Centers for Medicare & Medicaid Services (CMS) is committed to fostering innovation while ensuring that people
Read MoreKFF Survey Shows Complexity, Red Tape, Denials, Confusion Rivals Affordability as a Problem for Insured Consumers, With Some Saying It Caused Them to Go Without or Delay Care
(Contact Craig Palosky for the Kaiser Family Foundation published June 15, 2023) Most (58%) people with health insurance say they
Read MoreVA hospitals are outperforming private hospitals, latest Medicare survey shows
(By Quil Lawrence for NPR) A nationwide Medicare survey released today found that veterans rated Veterans Affairs hospitals higher than
Read MoreThe current Medicare Advantage payment structure results in overpayments
Current research states that the millions of beneficiaries in traditional Medicare who have switched to Medicare Advantage plans have lower
Read MoreInflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of
Read More